erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Dermatitis, Perioral D019557 4 associated lipids
Scleritis D015423 3 associated lipids
Impetigo D007169 3 associated lipids
Neuroaspergillosis D020953 2 associated lipids
Granulomatosis, Orofacial D051261 2 associated lipids
Jejunal Diseases D007579 3 associated lipids
Ileus D045823 3 associated lipids
Pneumonia, Mycoplasma D011019 6 associated lipids
Neisseriaceae Infections D016870 3 associated lipids
Desulfovibrionaceae Infections D045824 5 associated lipids
Periodontal Abscess D010508 2 associated lipids
Chancroid D002602 4 associated lipids
Sexually Transmitted Diseases, Bacterial D015231 5 associated lipids
Angiomatosis D000798 1 associated lipids
Vulvovaginitis D014848 2 associated lipids
Fever of Unknown Origin D005335 3 associated lipids
Conjunctivitis, Bacterial D003234 3 associated lipids
Gardner Syndrome D005736 2 associated lipids
Psittacosis D009956 4 associated lipids
Conjunctivitis, Inclusion D003235 4 associated lipids
Angiomatosis, Bacillary D016917 2 associated lipids
Ophthalmia Neonatorum D009878 1 associated lipids
Typhus, Endemic Flea-Borne D014437 3 associated lipids
Hereditary Sensory and Autonomic Neuropathies D009477 1 associated lipids
Epidermitis, Exudative, of Swine D004818 1 associated lipids
Urethral Diseases D014522 4 associated lipids
Mycetoma D008271 4 associated lipids
Chlamydiaceae Infections D002694 2 associated lipids
Diphtheria D004165 2 associated lipids
Typhus, Epidemic Louse-Borne D014438 1 associated lipids
Nasopharyngitis D009304 2 associated lipids
Empyema D004653 3 associated lipids
Lymphogranuloma Venereum D008219 4 associated lipids
Erysipelas D004886 1 associated lipids
Protein-Losing Enteropathies D011504 2 associated lipids
Focal Infection, Dental D005491 1 associated lipids
Actinomycosis, Cervicofacial D000197 1 associated lipids
Keratoderma, Palmoplantar D007645 1 associated lipids
Papillon-Lefevre Disease D010214 1 associated lipids
Syphilis, Cutaneous D013591 1 associated lipids
Superinfection D015163 3 associated lipids
Otitis Media, Suppurative D010035 4 associated lipids
Bites, Human D001734 2 associated lipids
Dacryocystitis D003607 1 associated lipids
Peritonsillar Abscess D000039 1 associated lipids
Parapsoriasis D010267 1 associated lipids
Rickettsia Infections D012282 5 associated lipids
Spider Bites D001098 1 associated lipids
Pharyngeal Diseases D010608 4 associated lipids
Meningitis, Haemophilus D008583 3 associated lipids
Lacrimal Duct Obstruction D007767 1 associated lipids
Pilonidal Sinus D010864 1 associated lipids
Granuloma Inguinale D006100 2 associated lipids
Erythema Chronicum Migrans D015787 3 associated lipids
Sporotrichosis D013174 3 associated lipids
Ehrlichiosis D016873 2 associated lipids
Rat-Bite Fever D011906 1 associated lipids
Rubella D012409 2 associated lipids
Pleural Diseases D010995 4 associated lipids
Maxillofacial Injuries D008446 1 associated lipids
Pericarditis, Constrictive D010494 1 associated lipids
Syphilis, Cardiovascular D013589 1 associated lipids
Meningitis, Listeria D008584 1 associated lipids
Erythema Multiforme D004892 3 associated lipids
Prolapse D011391 1 associated lipids
Gas Gangrene D005738 1 associated lipids
Hearing Loss, Conductive D006314 2 associated lipids
Erythrasma D004894 1 associated lipids
Granuloma, Pyogenic D017789 2 associated lipids
Retropharyngeal Abscess D017703 2 associated lipids
Postgastrectomy Syndromes D011178 2 associated lipids
Heart Murmurs D006337 1 associated lipids
Rickettsiaceae Infections D012288 2 associated lipids
Bartonella Infections D001474 3 associated lipids
Scarlet Fever D012541 1 associated lipids
Auditory Diseases, Central D001304 2 associated lipids
Ethmoid Sinusitis D015521 2 associated lipids
Otorhinolaryngologic Diseases D010038 3 associated lipids
Dry Socket D004368 3 associated lipids
Hearing Loss, Functional D006315 2 associated lipids
Nasopharyngeal Diseases D009302 2 associated lipids
Endocarditis, Subacute Bacterial D004698 1 associated lipids
Uterine Cervical Erosion D002579 2 associated lipids
Sialadenitis D012793 1 associated lipids
Peliosis Hepatis D010382 1 associated lipids
Thyroid Crisis D013958 1 associated lipids
Megacolon D008531 1 associated lipids
Relapsing Fever D012061 3 associated lipids
Carbuncle D002270 1 associated lipids
Furunculosis D005667 2 associated lipids
Hyperhidrosis D006945 2 associated lipids
Jaw Abnormalities D007569 1 associated lipids
Skin Diseases, Vascular D017445 1 associated lipids
Marfan Syndrome D008382 2 associated lipids
Elephantiasis D004604 2 associated lipids
Lymphangitis D008205 4 associated lipids
Gastric Outlet Obstruction D017219 1 associated lipids
Hyperemesis Gravidarum D006939 2 associated lipids
Empyema, Pleural D016724 2 associated lipids
Lymphoma, B-Cell, Marginal Zone D018442 1 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Katrush VR and Zhukovskaia SA [Separation of emulsions during extraction of antibiotics from native solutions]. 1987 Antibiot. Med. Biotekhnol. pmid:3606053
Tsirkin RS [Antibiotic sensitivity of staphylococci associated with adenoviruses]. 1985 Antibiot. Med. Biotekhnol. pmid:3923916
Kuznetsov LE [Effect of a temperature regimen on erythromycin biosynthesis]. 1985 Antibiot. Med. Biotekhnol. pmid:4051468
Efimova OG et al. [Electron microscopic study of the interaction of cultures of Bordetella pertussis altered by antibiotic action with a human amniotic cell culture]. 1986 Antibiot. Med. Biotekhnol. pmid:2878640
Gusakova GV et al. [IR spectral research on erythromycin mono- and dihydrates]. 1986 Antibiot. Med. Biotekhnol. pmid:3777893
Gusakova GV et al. [Infrared spectra and the molecular conformations of macrolide-group antibiotics in solution]. 1986 Antibiot. Med. Biotekhnol. pmid:3777894
Zurabyan VA et al. [In vitro influence of biologically active factors of microorganisms on antibiotic susceptibility of Yersinia pestis]. 1997 Antibiot. Khimioter. pmid:9463297
Sadovnikova SF and Selina EV [Five years of sumamed on Russian market]. 1997 Antibiot. Khimioter. pmid:9463300
Ukhabotina LS et al. [Cloning of clusters of erythromycin biosynthesis genes of Streptomyces erythraeus (Saccharopolyspora erythraea)]. 1990 Antibiot. Khimioter. pmid:2150305
Sytnik SI [Antibiotic sensitivity of Staphylococci populating the breast skin of nursing women]. 1989 Antibiot. Khimioter. pmid:2730223
Bulgakova VG et al. [Metabolism of alpha-ketoacids in erythromycin biosynthesis in various strains of Saccharopolyspora erythraea]. 1993 Antibiot. Khimioter. pmid:8166559
Kirichenko VN et al. [Use of protoplast fusion in the selection of erythromycin-producing strains of Saccharopolyspora erythraea]. 1993 Antibiot. Khimioter. pmid:8166562
Strachynskił LS et al. [Pharmacoepidemiology of antibiotics in the treatment of respiratory tract infections in pediatric outpatients]. 1997 Antibiot. Khimioter. pmid:9412396
Nastasyak IN [Localization of rifampicin resistance determinants on genetic map of Saccharopolyspora erythraea]. 1997 Antibiot. Khimioter. pmid:9412406
Zavorotnaia SA et al. [Genetic instability of the feature of streptomycin resistance in Streptomyces erythraeus]. 1990 Antibiot. Khimioter. pmid:2078071
StrachunskiÄ­ LS et al. [Comparative clinical effectiveness and tolerance of azithromycin (sumamed) and erythromycin in patients with sinusitis]. 1993 Antibiot. Khimioter. pmid:8060176
Shubin SV et al. [Effectiveness of azithromycin relative to chlamydia infection in reactive arthritis]. 1993 Antibiot. Khimioter. pmid:8060177
Kirichenko NV et al. [Isolation and characterization of genetic recombinants in protoplast fusion in Saccharopolyspora erythraea]. 1993 Antibiot. Khimioter. pmid:8060179
Fomina IP et al. [Azithromycin (sumamed)--in the treatment of respiratory tract infections]. 1996 Antibiot. Khimioter. pmid:8929121
Ukhabotina LS et al. [Identification and characteristics of plasmids of the strains of erythromycin-producing Streptomyces erythreus]. 1988 Antibiot. Khimioter. pmid:2837155
Sazykin IuO [Modern macrolides and azalides in the therapy of infectious-inflammatory diseases. A seminar, February 1994, Moscow]. 1994 Feb-Mar Antibiot. Khimioter. pmid:7979801
Lialikov SA et al. [Monitoring of side effects and estimation of cycloferon efficacy in treatment of children with frequent and prolonged diseases]. 2012 Antibiot. Khimioter. pmid:23700934
Kolpakov AI et al. [Use of exogenous ribonuclease for improvement of Lactobacillus biological properties]. 1998 Antibiot. Khimioter. pmid:9791680
Platonova MM et al. [Clinical significance of fungal and microbial associations and antibacterial therapy for treatment of chronic inflammatory respiratory tract diseases in children]. 1998 Antibiot. Khimioter. pmid:9791682
Oriabinskaia LB et al. [Energy metabolism in Staphylococci containing plasmids of resistance to a number of antibiotics]. 1992 Antibiot. Khimioter. pmid:1296533
Grigor'ev AE et al. [Construction of hybrid plasmids containing genes for erythromycin biosynthesis and amplifying sequence AUD-Sr1 of Streptomyces rimosus]. 1992 Antibiot. Khimioter. pmid:1296539
Kurmanova KB et al. [Efficacy of pefloxacin in the treatment of complicated relapsing erysipelas]. 1997 Antibiot. Khimioter. pmid:9480650
Gagaeva EV and Firsov AA [Pharmacokinetics of protegentin, a combined preparation]. 1991 Antibiot. Khimioter. pmid:1953168
Arzumanian OG et al. [Effect of partial pressure of solute oxygen on the intensity of respiration of cultures of antibiotic producers]. 1990 Antibiot. Khimioter. pmid:2334239
Zakharova GM et al. [Study of the effect of protoplast formation on the antibiotic activity of erythromycin producers]. 1990 Antibiot. Khimioter. pmid:2334241
Grudinina SA et al. [Dynamics of Streptococcos pneumoniae antibiotic resistance extension in Moscow in 1998-2003]. 2004 Antibiot. Khimioter. pmid:15460020
Navashin SM and Nikitin AV [New macrolide antibiotics, rifamycins and peptide antibiotics discussed at the 27th International Conference on Antimicrobial Agents and Chemotherapy]. 1991 Antibiot. Khimioter. pmid:1850977
Nazarov AD et al. [Erythromycin pharmacokinetics in children after rectal and oral administration]. 1991 Antibiot. Khimioter. pmid:2025118
Korenev SV et al. [Pharmacological availability of erythromycin granules for children's use]. 1990 Antibiot. Khimioter. pmid:2264745
Bryzgalova TE et al. [Conditions for immobilizing Streptomyces erythreus in a calcium alginate gel and the apparatus setup for the process]. 1988 Antibiot. Khimioter. pmid:3288145
Vasilos LV et al. [Chemotherapeutic effectiveness of erythromycin, rifampicin and tetracyclines in chlamydiosis and mycoplasmosis in children]. 1995 Antibiot. Khimioter. pmid:8593094
BureÄ­ko SF et al. [Various properties of erythromycin basicity]. 1992 Antibiot. Khimioter. pmid:1514846
Dolgova GV et al. [Experimental study of a novel formulation for local application based on gentamicin, erythromycin and protease C]. 1990 Antibiot. Khimioter. pmid:2275587
Nigmatulin AZ et al. [Antibiotic binding by leukocytes from brucellosis patients]. 1990 Antibiot. Khimioter. pmid:2275592
Kotova NV [Kinetic and equilibrium parameters of erythromycin sorption on various sorbents]. 2009 Antibiot. Khimioter. pmid:20583559
Belousov IuB et al. [Dirithromycin in the treatment of infections of the lower respiratory tract]. 1995 Antibiot. Khimioter. pmid:8645058
Minaeva NZ et al. [Bacteria of the genus Arcobacter, a new etiological factor of nosocomial infections]. 2006 Antibiot. Khimioter. pmid:16878388
Gurevich KG et al. [Comparative pharmacokinetics of erythromycin target cell-associated transport and intravenous administration in patients with pneumonia]. 2006 Antibiot. Khimioter. pmid:18030786
Motina GL et al. [Effect of the methods of sterilization on the quality of nutrient media and on the level of antibiotic production]. 1991 Antibiot. Khimioter. pmid:1814272
Michurina TA et al. [Antioxidant effect on the growth of Saccharopolyspora erythraea and biosynthesis of erythromycins]. 2005 Antibiot. Khimioter. pmid:19140479
Petrova MS et al. [Antibiotic therapy in children with pertussis]. 1992 Antibiot. Khimioter. pmid:1300936
Berezhinskaia VV and Dolgova GV [Macrolide antibiotics and their use in combined pharmacotherapy]. 1989 Antibiot. Khimioter. pmid:2686571
Sereda EV et al. [Use of oral macrolide and azalide antibiotics in children with bronchopulmonary diseases]. 1994 Antibiot. Khimioter. pmid:7840711
Sazykin IuO et al. [Ketolides--erythromycin derivatives with activity against macrolide-resistant bacteria]. 2000 Antibiot. Khimioter. pmid:10707799
MashkilleÄ­son AL [Azithromycin in the treatment of syphilis]. 1994 Antibiot. Khimioter. pmid:7848005
Guchev IA et al. [Efficacy and safety of azithromycin prophylaxis of respiratory tract infections in military community]. 2004 Antibiot. Khimioter. pmid:15727144
Fomina IP [Second international conference on macrolides, azalides and streptogramins (Venice, Italy, January 19-22, 1994)]. 1994 Antibiot. Khimioter. pmid:7914722
Pozdniakova VP et al. [Protegentin--a combined preparation for the local treatment of suppurative infection]. 1993 Oct-Nov Antibiot. Khimioter. pmid:8085892
WILLIAMSON GM and ZINNEMANN K The susceptibility of coliform bacilli to erythromycin. 1962 Antibiot Chemother (Northfield) pmid:14007243
KIRBY WM et al. Erythromycin serum concentrations following administration in acid-resistant tablets. 1953 Antibiot Chemother (Northfield) pmid:24542409
KIRSHBAUM A et al. A cupplate method for the determination of erythromycin concentrations in serum and other body fluids. 1953 Antibiot Chemother (Northfield) pmid:24542421
CLARK RK The chemistry of erythromycin. I. Acid degradation products. 1953 Antibiot Chemother (Northfield) pmid:24542535
MAPLE FM et al. Serum concentrations of erythromycin following intravenous administration. 1953 Antibiot Chemother (Northfield) pmid:24542586
LEE CC et al. Tissue distribution of erythromycin in rats. 1953 Antibiot Chemother (Northfield) pmid:24542649
SYLVESTER JC and JOSSELYN LE Absorption of erythromycin. II. Erythromycin stearate. 1953 Antibiot Chemother (Northfield) pmid:24542651
GRIGSBY ME et al. Some laboratory and clinical experiences with erythromycin. 1953 Antibiot Chemother (Northfield) pmid:24542704
HASBROUCK RB and GARVEN FC The chemistry of erythromycin. II. Acid degradation products. 1953 Antibiot Chemother (Northfield) pmid:24542706
ANDERSON EA Cure of resistant meningococcemia with erythromycin. 1953 Antibiot Chemother (Northfield) pmid:24542853
HAIGHT TH et al. Erythromycin therapy of respiratory infections. II. Effects of varying durations of therapy of streptococcal infections on eradication of streptococci and on formation of antistreptolysin O. 1954 Antibiot Chemother (Northfield) pmid:24543018
LAING CR and SCOTT RB Erythromycin-polymyxin ointment in the treatment of pyoderma in children. 1954 Antibiot Chemother (Northfield) pmid:24543095
TUNEVALL G and HEDENIUS P Laboratory and clinical studies with erythromycin. 1954 Antibiot Chemother (Northfield) pmid:24543103
LEE CC et al. Site of absorption of erythromycin in rats. 1954 Antibiot Chemother (Northfield) pmid:24543219
MANTEN A Synergism and antagonism between antibiotic mixtures containing erythromycin. 1954 Antibiot Chemother (Northfield) pmid:24543317
KUZEL NR et al. Spectrophotometric determination of erythromycin in pharmaceutical products. 1954 Antibiot Chemother (Northfield) pmid:24543318
CLARK RK and TATERKA M The chemistry of erythromycin. III. Acid degradation products of erythromycin B. 1955 Antibiot Chemother (Northfield) pmid:24543468
CLARK RK and FREIFELDER M The synthesis of new erythromycins. 1957 Antibiot Chemother (Northfield) pmid:24544531
LEE CC et al. Further pharmacological studies on propionyl erythromycin ester lauryl sulfate. 1961 Antibiot Chemother (Northfield) pmid:13760219
CLARK RK and VARNER EL New esters of erythromycin. 1957 Antibiot Chemother (Northfield) pmid:24544532
MANIAR AC et al. A comparison of the in vitro and in vivo activity of erythromycin and spiramycin. 1960 Antibiot Chemother (Northfield) pmid:13766168
ROBINSON MM Demonstration by "challenge" of hepatic dysfunction associated with propionyl erythromycin ester lauryl sulfate. 1962 Antibiot Chemother (Northfield) pmid:14492925
GRIFFITH RS and BLACK HR A comparison of blood levels after oral administration of erythromycin and erythromycin estolate. 1962 Antibiot Chemother (Northfield) pmid:13901859
GRIFFITH RS and BLACK HR Comparison of antimicrobial activity of erythromycin estolate and demethylchlortetracycline against hemolytic streptococci. 1962 Antibiot Chemother (Northfield) pmid:13901860
GRIFFITH RS The ratio of antimicrobial activity between propionyl erythromycin lauryl sulfate and erythromycin ethyl carbonate. 1961 Antibiot Chemother (Northfield) pmid:13901862
GROGAN JB et al. Antibiotic susceptibility of phage type 80/81 strains of staphylococci isolated from hospital and community populations. 1962 Antibiot Chemother (Northfield) pmid:13902091
CORDERO FA Propionyl erythromycin ester lauryl sulfate in the treatment of treponematosis and chancroid. 1961 Antibiot Chemother (Northfield) pmid:13881298
STROM J Penicillin and erythromycin singly and in combination in scarlatina therapy and the interference between them. 1961 Antibiot Chemother (Northfield) pmid:13917845
LIMSON BM Lauryl sulfate salt of propionyl erythromycin: antibacterial activity in serum and therapeutic evaluation of low doses. 1961 Antibiot Chemother (Northfield) pmid:14465340
SALDANA TATE L In vivo and in vitro evaluation of oleandomycin, erythromycin, and tetracycline against cultures of Staphylococcus aureus. 1960 Antibiot Chemother (Northfield) pmid:14440930
SCHNEIERSON SS et al. Inhibition of Pseudomonas aeruginosa pigment formation by chloramphenicol and erythromycin. 1960 Antibiot Chemother (Northfield) pmid:14443279
Schmid EE The macrolide group of antibiotics. Mode of action. 1971 Antibiot Chemother (1971) pmid:4951002
Connamacher RH Inducible bacterial resistance. 1975 Antibiot Chemother (1971) pmid:773276
Wilson JT and van Boxtel CJ Pharmacokinetics of Erythromycin in man. 1978 Antibiot Chemother (1971) pmid:27136
Tanimoto H A review of the recent progress in treatment of patients with diffuse panbronchiolitis associated with Pseudomonas aeruginosa infection in Japan. 1991 Antibiot Chemother (1971) pmid:1801651
FORFAR JO and MACCABE AF Erythromycin--a review. 1957 Antibiot Chemother pmid:13488431
Siegenthaler W et al. [New antibiotics, with the exception of penicillins, streptomycin, tetracyclines and chloramphenicol]. 1968 Antibiot Chemother pmid:4302993
FOX RT et al. Clinical and laboratory experiences with erythromycin in treatment of thoracic empyema. 1955-1956 Antibiot Annu pmid:13355244
CALESNICK B Effectiveness of oral erythromycin propionate in commonly occurring infections. 1959-1960 Antibiot Annu pmid:13806941
DAVIS DS et al. The treatment of one hundred and seventy-one patients with erythromycin, including one hundred and thirty-two with bacterial pneumonia. 1955-1956 Antibiot Annu pmid:13355245
LOUGHLIN EH et al. Antibiotic therapy of acute gonococcal infections; a study of the comparative efficacy of triacetyloleandomycin, erythromycin, and penicillin V in the treatment of acute gonococcal urethritis. 1958-1959 Antibiot Annu pmid:13637747
STEPHENS VC and CONINE JW Esters of erythromycin. III. Esters of low molecular weight aliphatic acids. 1958-1959 Antibiot Annu pmid:13637765
LEE CC et al. Pharmacology and toxicology of erythromycin propionate. 1958-1959 Antibiot Annu pmid:13637766
GRIFFITH RS Laboratory and clinical studies with erythromycin propionate. 1958-1959 Antibiot Annu pmid:13637767
PERRY DM et al. Clinical and laboratory studies of erythromycin propionate. 1958-1959 Antibiot Annu pmid:13637768
MARMELL M et al. Clinical trial of erythromycin propionate for acute anterior gonococcal urethritis. 1959-1960 Antibiot Annu pmid:14421354
REICHELDERFER TE et al. Clinical studies of propionyl erythromycin lauryl sulfate in children. 1959-1960 Antibiot Annu pmid:14437052